Drug Utilization Pattern and Potential Teratogenicity Risk among Pregnant Women Visiting Antenatal Clinic: The Case of a Primary Hospital

Published on:27th Mar, 2015
Indian Journal of Pharmacy Practice, 2015; 8(1):27-33
Research Article | doi:10.5530/ijopp.8.1.6


Drug Utilization Pattern and Potential Teratogenicity Risk among Pregnant Women Visiting Antenatal Clinic: The Case of a Primary Hospital


Authors and affiliation (s):

Mesfin Fikadu, Dereje Kebebe, Wote Amelo and  Fanta Gashe*

Department of Pharmacy, College of Public Health and Medical Sciences, Jimma University, Ethiopia.

Abstract:

Background: Pregnancy is a special physiological condition where the treatment needs a special concern. Moreover, pharmacotherapy during pregnancy is very challenging since only a few medicines have been specifically tested for safety. Objective: The aim of this study was to evaluate the utilization pattern and the teratogenicity risk of the drugs prescribed to pregnant women in Fiche Hospital, Ethiopia. Methods: A retrospective study was conducted by reviewing medical case files of 323 pregnant women, encountered with at least one drug, out of 876 pregnant women attending antenatal clinic from February 09/2013 to March 09/2014. The prescription pattern was assessed from perspectives of World Health Organization (WHO) core drug use indicators, and the United States Food and Drug Administration (FDA) fetal harm classification. Results: Among 1876 pregnant women who visited ANC clinic, a total of 323 women received 456 medications. The age of the patients was within the range of 16-49 years and the majority of them (77.22%) were within the age group of 20-35 years. The majority of pregnant women (80.47%) visited antenatal care (ANC) during their first trimester gestation. Out of the total drugs prescribed, category A drugs comprised 20.83%, category B (26.34%), category C (24.34%), category C/D (9.65%), category D (9.43%) and category X (1.09%). Percentage of encounter with antibiotics and injectable drugs were 31.8% and 19.30%, respectively. Conclusion: Approximately half of the pregnant women utilized drugs from FDA category C, D and X which are thought to cause fetal harm; therefore, the use of these drugs should be minimized.

Key words: FDA drug category, Pregnancy, Teratogen, Trimester, WHO core drug prescribing indicators.




 

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.

DOI HISTORY

IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs